Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT
- 154 Downloads
Since first proposed in 1999 by Larson et al. , the use of volumetric quantification techniques on PET/CT exams has become increasingly popular to evaluate tumor burden, especially with 18F-FDG. The volumetric quantification of tumor burden has been shown to correlate with prognosis and is also an objective means to evaluate response to treatment in a variety of cancers .
Skeletal tumor burden (FTV and TFL) is obtained by volumetric quantification of 18F-fluoride PET/CT studies and could be used as an imaging biomarker for evaluation of prognosis and response to therapy for many cancers. FTV and TFL can be measured manually or semiautomatically. We will demonstrate the step-by-step quantification process both manually and semi-automatically.
- 1.Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2:159–71.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Wassberg C, Lubberink M, Sörensen J, Johansson S. Repeatability of quantitative parameters of 18F-fluoride PET/CT and biochemical tumour and specific bone remodelling markers in prostate cancer bone metastases. EJNMMI Res. 2017;7:42.Google Scholar
- 6.Brito AE, Santos A, Sasse AD, et al. 18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer. Oncotarget. 2017;8:36001.Google Scholar